Vascular Sealing Medical Glue Market By Procedure (Revascularization, Others) , By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Vascular Sealing Medical Glue Market By Procedure (Revascularization, Others) , By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033


The vascular sealing medical glue market was valued at $0.7 billion in 2023, and is projected to reach $1.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.
Vascular sealing medical glue is a surgical adhesive that possesses high adhesive and hemostatic properties, and is used to seal and reinforce tissues. These adhesives are play a pivotal role in creating functional connections between damaged tissues and between tissues and implanted biomaterials. They are majorly developed to minimize the use of surgical sutures and mechanical methods of tissue fusion, which are useful in conventional surgeries. This is attributed to the fact that vascular sealing glues promote tissue regeneration and healing, mitigate the risk of infection, and minimize tissue trauma as compared to conventional methods. Natural medical adhesives available in the market include fibrin adhesives and collagen-based products, which are highly effective in adhesion.
The growth of the global vascular sealing medical glue market is majorly driven by alarming rise in prevalence of cardiovascular diseases and corresponding increase in need for surgeries, such as angioplasty and coronary artery bypass grafting, are boosting the demand for vascular sealing medical glue. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases and often require procedures to address issues such as varicose veins and atherosclerosis, thus increasing the need for vascular sealing glues. As per the article published by the Revista Española de Cardiología—the official publication of the Spanish Society of Cardiology—coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers due to quicker recovery times and reduced hospital stays fosters the growth of the market. However, safety concerns associated with vascular sealing medical glue hamper the growth of the market. For instance, some adhesives are cytotoxic and are poorly absorbed, which limit their demand in healthcare settings. Furthermore, inability to medical adhesives to provide adequate and immediate seal, increased risk of infection, and delayed healing act as the key deterrent factors of the market. On the contrary, to reduce the risk of infection at the surgical sites, manufacturers are developing vascular sealing medical glue with antimicrobial properties, thus ensuring post-operative care and patient safety. In addition, continuous innovations in the formulation of medical glues to enhance their adhesive strength are expected to offer lucrative opportunities for the expansion of the market during the forecast period.
The global vascular sealing medical glue market is segmented into procedure, end user, and region. By procedure, the market is categorized into revascularization and others. On the basis of end user, it is divided into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By procedure, the revascularization segment dominated the market share in 2023.
On the basis of end user, the hospitals segment exhibited the highest growth in 2023.
Region wise, North America lead the market in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global vascular sealing medical glue market include Baxter International Inc., Becton, Dickinson and Company, Artivion, Inc., Success Bio-tech, Integra LifeSciences Holdings Corporation, Stryker Corporation, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Key Market Segments

By Procedure

Revascularization
Others

By End User

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Baxter International Inc.
Becton, Dickinson and Company
Artivion, Inc.
Success Bio-tech
Integra LifeSciences Holdings Corporation
Stryker Corporation
Abbott Laboratories
Terumo Corporation
Johnson & Johnson
Medtronic


CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Procedure
4.2. Revascularization
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Others
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Specialty Clinics
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Ambulatory Surgical Centers
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: VASCULAR SEALING MEDICAL GLUE MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Procedure
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Vascular Sealing Medical Glue Market
6.2.5.1. Market Size and Forecast, By Procedure
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Vascular Sealing Medical Glue Market
6.2.6.1. Market Size and Forecast, By Procedure
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Vascular Sealing Medical Glue Market
6.2.7.1. Market Size and Forecast, By Procedure
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Procedure
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Vascular Sealing Medical Glue Market
6.3.5.1. Market Size and Forecast, By Procedure
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Vascular Sealing Medical Glue Market
6.3.6.1. Market Size and Forecast, By Procedure
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Vascular Sealing Medical Glue Market
6.3.7.1. Market Size and Forecast, By Procedure
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Vascular Sealing Medical Glue Market
6.3.8.1. Market Size and Forecast, By Procedure
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Vascular Sealing Medical Glue Market
6.3.9.1. Market Size and Forecast, By Procedure
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Vascular Sealing Medical Glue Market
6.3.10.1. Market Size and Forecast, By Procedure
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Procedure
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Vascular Sealing Medical Glue Market
6.4.5.1. Market Size and Forecast, By Procedure
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Vascular Sealing Medical Glue Market
6.4.6.1. Market Size and Forecast, By Procedure
6.4.6.2. Market Size and Forecast, By End User
6.4.7. Australia Vascular Sealing Medical Glue Market
6.4.7.1. Market Size and Forecast, By Procedure
6.4.7.2. Market Size and Forecast, By End User
6.4.8. India Vascular Sealing Medical Glue Market
6.4.8.1. Market Size and Forecast, By Procedure
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Vascular Sealing Medical Glue Market
6.4.9.1. Market Size and Forecast, By Procedure
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Vascular Sealing Medical Glue Market
6.4.10.1. Market Size and Forecast, By Procedure
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Procedure
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Vascular Sealing Medical Glue Market
6.5.5.1. Market Size and Forecast, By Procedure
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Vascular Sealing Medical Glue Market
6.5.6.1. Market Size and Forecast, By Procedure
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Vascular Sealing Medical Glue Market
6.5.7.1. Market Size and Forecast, By Procedure
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Vascular Sealing Medical Glue Market
6.5.8.1. Market Size and Forecast, By Procedure
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Baxter International Inc.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Becton, Dickinson And Company
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Artivion, Inc.
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Success Bio-tech
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Integra LifeSciences Holdings Corporation
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Stryker Corporation
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Abbott Laboratories
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Terumo Corporation
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Johnson And Johnson
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Medtronic
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 2. VASCULAR SEALING MEDICAL GLUE MARKET FOR REVASCULARIZATION, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. VASCULAR SEALING MEDICAL GLUE MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 5. VASCULAR SEALING MEDICAL GLUE MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. VASCULAR SEALING MEDICAL GLUE MARKET FOR SPECIALTY CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. VASCULAR SEALING MEDICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. VASCULAR SEALING MEDICAL GLUE MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. NORTH AMERICA VASCULAR SEALING MEDICAL GLUE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 10. NORTH AMERICA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 11. NORTH AMERICA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 12. U.S. VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 13. U.S. VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 14. CANADA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 15. CANADA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 16. MEXICO VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 17. MEXICO VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 18. EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 19. EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 20. EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 21. GERMANY VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 22. GERMANY VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. FRANCE VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 24. FRANCE VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 25. UK VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 26. UK VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. ITALY VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 28. ITALY VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. SPAIN VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 30. SPAIN VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 31. REST OF EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 32. REST OF EUROPE VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 34. ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 35. ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. JAPAN VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 37. JAPAN VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 38. CHINA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 39. CHINA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 40. AUSTRALIA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 41. AUSTRALIA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. INDIA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 43. INDIA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 44. SOUTH KOREA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 45. SOUTH KOREA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. REST OF ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 47. REST OF ASIA-PACIFIC VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 49. LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 50. LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 51. BRAZIL VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 52. BRAZIL VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 53. SAUDI ARABIA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 54. SAUDI ARABIA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. SOUTH AFRICA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 56. SOUTH AFRICA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 57. REST OF LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 58. REST OF LAMEA VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 60. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 61. BAXTER INTERNATIONAL INC.: OPERATING SEGMENTS
TABLE 62. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 63. BAXTER INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 64. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 65. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 66. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 67. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 68. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69. ARTIVION, INC.: KEY EXECUTIVES
TABLE 70. ARTIVION, INC.: COMPANY SNAPSHOT
TABLE 71. ARTIVION, INC.: OPERATING SEGMENTS
TABLE 72. ARTIVION, INC.: PRODUCT PORTFOLIO
TABLE 73. ARTIVION, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74. SUCCESS BIO-TECH: KEY EXECUTIVES
TABLE 75. SUCCESS BIO-TECH: COMPANY SNAPSHOT
TABLE 76. SUCCESS BIO-TECH: OPERATING SEGMENTS
TABLE 77. SUCCESS BIO-TECH: PRODUCT PORTFOLIO
TABLE 78. SUCCESS BIO-TECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 80. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 81. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
TABLE 82. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 83. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 85. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 86. STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 87. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 88. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 90. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 91. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 92. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 93. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 95. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 96. TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 97. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 98. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 100. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 101. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 102. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 103. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. MEDTRONIC: KEY EXECUTIVES
TABLE 105. MEDTRONIC: COMPANY SNAPSHOT
TABLE 106. MEDTRONIC: OPERATING SEGMENTS
TABLE 107. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 108. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF VASCULAR SEALING MEDICAL GLUE MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN VASCULAR SEALING MEDICAL GLUE MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALVASCULAR SEALING MEDICAL GLUE MARKET
FIGURE 10. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET SEGMENTATION, BY PROCEDURE
FIGURE 11. VASCULAR SEALING MEDICAL GLUE MARKET FOR REVASCULARIZATION, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. VASCULAR SEALING MEDICAL GLUE MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL VASCULAR SEALING MEDICAL GLUE MARKET SEGMENTATION, BY END USER
FIGURE 14. VASCULAR SEALING MEDICAL GLUE MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. VASCULAR SEALING MEDICAL GLUE MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. VASCULAR SEALING MEDICAL GLUE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 21. COMPETITIVE DASHBOARD
FIGURE 22. COMPETITIVE HEATMAP: VASCULAR SEALING MEDICAL GLUE MARKET
FIGURE 23. TOP PLAYER POSITIONING, 2023
FIGURE 24. BAXTER INTERNATIONAL INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. BAXTER INTERNATIONAL INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. ARTIVION, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. ARTIVION, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. ARTIVION, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. SUCCESS BIO-TECH: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. SUCCESS BIO-TECH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. SUCCESS BIO-TECH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. STRYKER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. TERUMO CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings